It is generally considered that cell-free protein synthesis systems are capable of generating only a small expression yield. Even if this was true in the 2000s, it is certainly no longer the case today (Carlson et al., 2012) as we will explain in the following paper.
Better expression yield results than E. coli systems for hard-to-express proteins.
In fact, yields obtained with cell-free systems are even higher than with cell-based systems for difficult-to-express proteins, such as membrane, cytotoxic and unstable proteins.
To illustrate this, cell-free systems supplemented with vesicles derived from E. coli inner membranes, have been used to produce two complex integral membrane transporters; the six- transmembrane mannitol permease (MtlA) and the twelve-transmembrane tetracycline pump (TetA) without the use of detergents or refolding steps. The two E. coli transporters MtlA and TetA were produced at yields 130±30 μg/mL and 570±50 μg/mL, respectively (Wuu et al., 2008). These yields were 60 and 400 times those typically achieved in cell-based systems. Furthermore, high expression yields above 0.5 g/L are nowadays frequently reported, with values greater than 2 g/L and 100 g/L for the highest reported!
These high expression yields were obtained for cell-free systems using optimized metabolism, with improved energy regeneration and by-product recycling. As an example, up to 1.7 g/L of chloramphenicol acetyl transferase and 2.3 g/L of a reporter protein deGFP were synthesized using maltodextrin or maltose to recycle inorganic phosphate and to regenerate ATP (Kim et al., 2011; Cashera et al., 2013).
High expression yields in E. coli-based cell-free systems were also reported for the production of multicopper oxidases (MCOs) that require four copper ions arranged in two distinct metal centers to perform their function (Li et al., 2016). Total yields of up to 1.2 g/L with more than 95% solubility were higher than cell-based expression titers, since low expression yields and challenging copper incorporation are observed in cell-based expression systems. In contrast, a significant amount of copper (100 μM) was present during cell-free synthesis without affecting expression yield and activity was stimulated by the addition of copper after translation.
Major advances were also made to obtain high expression yields of complex proteins containing multiple disulfide bonds (Carlson et al., 2012). Although yields below 0.1 g/L were obtained before 2010, secreted eukaryotic proteins such as rhGM-CSF are now produced in E. coli-based cell-free systems at 0.7 g/L (Zawada et al., 2011).
In conclusion, the combined advances in cell extract preparation, energy generating systems and disulfide bond formation mean that high yields can now be obtained by cell-free expression systems. Thus today, cell-free systems can challenge conventional expression systems and should be tested more systematically. The expression levels reached today with cell-free technology totally match with industrial scale production.
In vitro vs. In vivo for membrane proteins
- Système Cell-Free : 700 μg/mL
- Système cellulaire : 7 μg/mL
Récepteur à la bradykinin2
- Système Cell-Free : 85 μg/mL
- Système cellulaire : 0,1 μg/mL
- Système Cell-Free : 1000 μg/mL
- Système cellulaire : 10 μg/mL
Source: “Thromboplastine” and “Bradykinin receptor 2” proteins. Synthelis cell-free expression system Vs. cell-based system. Source: “Bak protein”. Svetlana Nedelkina, Isa Gokce, Helen Ridley, Céline Weckerle, Thierry Magnin,
François Vallette, Franc Pattus, Jeremy H. Lakey, Burkhard Bechinger , High-yield expression and purification of soluble forms of the anti-apoptotic Bcl-xL and Bcl-2 as TolAIII-fusion proteins, Elsevier, Protein Expression and Purification 60 (2008) 214–220..
Authors & sources
Carlson E.D., Gan R., Hodgman C.E., Jewett M.C. 2012. Cell-free protein synthesis: Applications come of age. Biotechnology Advances 30:1185–1194.
Caschera F., Noireaux V. 2013. Synthesis of 2.3 mg/ml of protein with an all Escherichia coli cell-free transcription-translation system. Biochimie 1-7.
Kim H.C., Kim T.W., Kim D.M. 2011. Prolonged production of proteins in a cell-free protein synthesis system using polymeric carbohydrates as an energy source. Process Biochem 46:1366–1369.
Li J., Lawton T.J., Kostecki J.S., Nisthal A., Fang J., Mayo S.L., Rosenzweig A.C., Jewett M.C. 2016. Cell-free protein synthesis enables high yielding synthesis of an active multicopper oxidase. Biotechnology Journal 11.
Wuu J.J., Swartz J.R. 2008. High yield cell-free production of integral membrane proteins without refolding or detergents. Biochimica y Biophysica Acta 1778 1237– 1250
Zawada J.F, Yin G., Steiner A.R., Yang J., Naresh A., Roy S.M., Gold D.S., Heinsohn H.G., Murray C.J. 2011. Microscale to manufacturing scale-up of cell-free cytokine production – A new approach for shortening protein production development timelines. Biotechnology Bioeng 108(7):1570-1578.